← Back to all trials
Completed
NCT07659223
Improving Outcomes for Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopahtic Arthritis
Sex: All
Ages: 0 Years – 16 Years
Healthy volunteers: No
Phase: NA
Enrollment: 116
Sponsor: Region Stockholm
Location: Karolinska University Hospital Stockholm
Summary
Children and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year after diagnosis. However, little is known about how a support program like JASP-1 can influence outcomes. Therefore, this study aimed to longitudinally examine registry data from children who participated in JASP 1 and to compare the outcomes with registry data from a matched control group.
Eligibility Criteria
Inclusion Criteria:
* For the JASP-1: Diagnosed with JIA and have completed the JASP-1.
* For the control group: Diagnosed with JIA at the same clinic as above
Exclusion Criteria:
* No JIA diagnosis
* Change of diagnose during the year
* Do not understand or speak Swedish
Source: ClinicalTrials.gov (NCT07659223). StuddyBuddy aggregates publicly available trial information.